Document:

Exhibit
10.4

 

THIS
WARRANT AND THE UNDERLYING SECURITIES HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”).
THEY MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED OR HYPOTHECATED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT AS TO SUCH
SECURITIES UNDER THE ACT OR AN OPINION OF COUNSEL SATISFACTORY TO THE COMPANY THAT SUCH REGISTRATION IS NOT REQUIRED.

 

ELECTROMEDICAL
TECHNOLOGIES, INC.

 

WARRANT
TO PURCHASE COMMON STOCK

 

	No. W-2	May 1,
    2020

 

VOID
AFTER MAY 1, 2025

 

THIS
CERTIFIES THAT, for value received, AGILITY FINANCIAL PARTNERS, LLC or assigns (the “Holder”), is entitled
to subscribe for and purchase from Electromedical Technologies, Inc., a Delaware corporation (the “Company”),
the Exercise Shares (as defined below) of the Company’s Common Stock on the terms and subject to the conditions set forth
below. This Warrant is being issued in connection with that certain Consulting Agreement among the Company and the consultants
party thereto dated as of September 7, 2016 (the “Consulting Agreement”).

 

DEFINITIONS.
As used herein, the following terms shall have the following respective meanings:

 

(a)
          “Acquisition” shall mean either (A) a merger, consolidation,
equity sale or similar transaction involving (directly or indirectly) the Company upon which, immediately after the consummation
of the transaction, the shareholders of the Company immediately prior thereto do not own, directly or indirectly, either (i) voting
securities representing more than 50% of the combined voting power of the surviving entity in such transaction, or (ii) securities
representing more than 50% of the combined voting power of the parent of the surviving entity in such transaction; or (B) a sale,
lease, transfer, exclusive license or other disposition, in a single transaction or series of related transactions, of all or
substantially all of the assets of the Company.

 

(b)
          “Exercise Period” shall mean the period commencing
with the date hereof and ending on May 1, 2025, unless sooner terminated as provided below.

 

(c)
          “Exercise Price” shall mean $0.52 per Exercise
Share subject to adjustment pursuant to Section 5 below.

 

(d)
          “Exercise Shares” shall mean up to 100,000 shares
of the Company’s Common Stock issuable upon exercise of this Warrant, subject to adjustment pursuant to the terms herein.

 

(e)
          “IPO” shall mean the Company’s first firm
commitment underwritten offering and sale of the Company’s Common Stock (the “Common Stock”) to the public
pursuant to an effective registration statement under the Securities Act of 1933, as amended (the “Act”). 

	 

     

     

    

	 	2.	EXERCISE OF WARRANT

 

(a)
          The rights represented by this Warrant may be exercised in whole or
in part at any time during the Exercise Period, by delivery of the following to the Company at its address set forth on the signature
page hereto (or at such other address as it may designate by notice in writing to the Holder):

 

(i)
An executed Notice of Exercise in the form attached hereto;

 

(ii)
Payment of the Exercise Price either in cash or by check; and

 

(iii)
This Warrant.

 

Upon
the exercise of the rights represented by this Warrant, a certificate or certificates for the Exercise Shares so purchased, registered
in the name of the Holder or persons affiliated with the Holder, if the Holder so designates, shall be issued and delivered to
the Holder within a reasonable time after the rights represented by this Warrant shall have been so exercised. In the event that
this Warrant is being exercised for less than all of the then-current number of Exercise Shares purchasable hereunder, the Company
shall, concurrently with the issuance by the Company of the number of Exercise Shares for which this Warrant is then being exercised,
issue a new Warrant exercisable for the remaining number of Exercise Shares purchasable hereunder.

 

The
person in whose name any certificate or certificates for Exercise Shares are to be issued upon exercise of this Warrant shall
be deemed to have become the holder of record of such shares on the date on which this Warrant was surrendered and payment of
the Exercise Price was made, irrespective of the date of delivery of such certificate or certificates, except that, if the date
of such surrender and payment is a date when the stock transfer books of the Company are closed, such person shall be deemed to
have become the holder of such shares at the close of business on the next succeeding date on which the stock transfer books are
open.

 

(b)
          Net Exercise. In lieu of cash exercising this Warrant, the Holder
of this Warrant may elect to receive shares equal to the value of this Warrant (or the portion thereof being canceled) by surrender
of this Warrant at the principal office of the Company together with notice of such election, in which event the Company shall
issue to the holder hereof a number of Shares computed using the following formula: X = Y (A-B) A Where X = the number of shares
of Common Stock to be issued to Holder. Y = the number of shares of Common Stock purchasable under the Warrants being exchanged
(as adjusted to the date of such calculation). A = the Market Price on the date of receipt by the Company of the exercise documents.
B = the Exercise Price of the Warrants being exchanged (as adjusted in accordance with the terms hereof). The “Market Price”
on any trading day shall be deemed to be the average of the ask and bid price of the Common Stock over the five (5) trading days
immediately preceding receipt by the Company of the exercise documents as officially reported by the principal securities exchange
or quotation medium on which the shares of Common Stock are listed or eligible for trading. If the Market Price cannot be determined
pursuant to the sentence above, the Market Price shall be determined in good faith (using customary valuation methods) by the
Board of Directors of the Company based on the information best available to it, including recent arms-length sales of Common
Stock to unaffiliated persons. 

	 

     

     

    

If,
within six (6) months from the date of this Warrant, the Holder sells the Exercise Shares and receives, net of commissions, amounts
outstanding due from Company, up to a maximum of $100,000, the Holder shall forgive the Debt owed to it by the Company and which
shall be deemed paid in full up to the maximum. If that does not occur within six months of the date of this Warrant, the Debt
shall remain in full force and effect, regardless of when the Holder is able to sell the Exercise Shares.

 

	 	3.	COVENANTS OF THE
    COMPANY.

 

3.1
          Covenants as to Exercise Shares. The Company covenants and
agrees that all Exercise Shares that may be issued upon the exercise of the rights represented by this Warrant and the shares
of the Company’s Common Stock that may be issued upon conversion of the Exercise Shares will, upon issuance, be validly
issued and outstanding, fully paid and nonassessable, and free from all taxes, liens and charges with respect to the issuance
thereof. The Company further covenants and agrees that the Company will at all times during the Exercise Period, have authorized
and reserved, free from preemptive rights, a sufficient number of shares of the series of equity securities comprising the Exercise
Shares to provide for the exercise of the rights represented by this Warrant and a sufficient number of shares of the Company’s
Common Stock to provide for the conversion of the Exercise Shares. If at any time during the Exercise Period the number of authorized
but unissued shares of such series of the Company’s equity securities shall not be sufficient to permit exercise of this
Warrant or the conversion of the Exercise Shares, the Company will take such corporate action as may, in the opinion of its counsel,
be necessary to increase its authorized but unissued shares of such series of the Company’s equity securities to such number
of shares as shall be sufficient for such purposes.

 

3.2
          Notices of Record Date. In the event of any taking by the Company
of a record of the holders of any class of securities for the purpose of determining the holders thereof who are entitled to receive
any dividend or other distribution, the Company shall mail to the Holder, at least 10 days prior to the date specified herein,
a notice specifying the date on which any such record is to be taken for the purpose of such dividend or distribution.

 

	 	4.	REPRESENTATIONS
    OF HOLDER.

 

4.1
          Acquisition of Warrant for Personal Account. The Holder
represents and warrants that it is acquiring the Warrant and the Exercise Shares solely for its account for investment and not
with a view to or for sale or distribution of said Warrant or Exercise Shares or any part thereof. The Holder also represents
that the entire legal and beneficial interests of the Warrant and Exercise Shares the Holder is acquiring is being acquired for,
and will be held for, its account only.

 

4.2
          Securities Are Not Registered.

 

(a)
          The Holder understands that the Warrant and the Exercise Shares
have not been registered under the Act on the basis that no distribution or public offering of the stock of the Company is to
be effected. The Holder realizes that the basis for the exemption may not be present if, notwithstanding its representations,
the Holder has a present intention of acquiring the securities for a fixed or determinable period in the future, selling (in connection
with a distribution or otherwise), granting any participation in, or otherwise distributing the securities. The Holder has no
such present intention. 

	 

     

     

    

(b)
          The Holder recognizes that the Warrant and the Exercise Shares
must be held indefinitely unless they are subsequently registered under the Act or an exemption from such registration is available.
The Holder recognizes that the Company has no obligation to register the Warrant or the Exercise Shares of the Company, or to
comply with any exemption from such registration.

 

(c)
          The Holder is aware that neither the Warrant nor the Exercise
Shares may be sold pursuant to Rule 144 adopted under the Act unless certain conditions are met, including, among other things,
the existence of a public market for the shares, the availability of certain current public information about the Company, the
resale following the required holding period under Rule 144 and the number of shares being sold during any three month period
not exceeding specified limitations. Holder is aware that the conditions for resale set forth in Rule 144 have not been satisfied
and that the Company presently has no plans to satisfy these conditions in the foreseeable future.

 

4.3
          Disposition of Warrant and Exercise Shares.

 

(a)
          The Holder further agrees not to make any disposition of all or
any part of the Warrant or Exercise Shares in any event unless and until:

 

(i)
          The Company shall have received a letter secured by the Holder
from the Securities and Exchange Commission stating that no action will be recommended to the Commission with respect to the proposed
disposition;

 

(ii)
         There is then in effect a registration statement under the Act covering
such proposed disposition and such disposition is made in accordance with said registration statement; or

 

(iii)
        The Holder shall have notified the Company of the proposed disposition and
shall have furnished the Company with a detailed statement of the circumstances surrounding the proposed disposition, and if reasonably
requested by the Company, the Holder shall have furnished the Company with an opinion of counsel, reasonably satisfactory to the
Company, for the Holder to the effect that such disposition will not require registration of such Warrant or Exercise Shares under
the Act or any applicable state securities laws. The Company agrees that it will not require an opinion of counsel with respect
to transactions under Rule 144 of the Securities Act of 1933, as amended, except in unusual circumstances.

 

(b)
          The Holder understands and agrees that all certificates evidencing
the shares to be issued to the Holder may bear the following legend:

 

THESE
SECURITIES HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”). THEY MAY NOT BE SOLD,
OFFERED FOR SALE, PLEDGED OR HYPOTHECATED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT AS TO THE SECURITIES UNDER THE
ACT OR AN OPINION OF COUNSEL SATISFACTORY TO THE COMPANY THAT SUCH REGISTRATION IS NOT REQUIRED.

 

	 

     

     

    

4.4
          Accredited Investor Status. The Holder is an “accredited
investor” as defined in Regulation D promulgated under the Act.

 

	 	5.	ADJUSTMENT OF EXERCISE
    PRICE AND NUMBER OF EXERCISE SHARES.

 

5.1
          Changes in Securities. In the event of changes in the series
of equity securities of the Company comprising the Exercise Shares by reason of stock dividends, splits, recapitalizations, reclassifications,
combinations or exchanges of shares, separations, reorganizations, liquidations, or the like, the number and class of Exercise
Shares available under the Warrant in the aggregate and the Exercise Price shall be correspondingly adjusted to give the Holder
of the Warrant, on exercise for the same aggregate Exercise Price, the total number, class, and kind of shares as the Holder would
have owned had the Warrant been exercised prior to the event and had the Holder continued to hold such shares until after the
event requiring adjustment. For purposes of this Section 5, the “aggregate Exercise Price” shall mean the aggregate
Exercise Price payable in connection with the exercise in full of this Warrant. The form of this Warrant need not be changed because
of any adjustment in the number of Exercise Shares subject to this Warrant. Whenever the Exercise Price or the number of shares
of Exercise Shares purchasable hereunder shall be adjusted pursuant to this Section 5.1, the Company at its expense shall issue
a certificate signed by an authorized officer setting forth, in reasonable detail, the event requiring the adjustment or readjustment,
the amount of the adjustment or readjustment and the Exercise Price and number of shares purchasable hereunder after giving effect
to such adjustment or readjustment, and shall cause a copy of such certificate to be mailed (by first-class mail, postage prepaid,
or overnight delivery service) to the Holder of the Warrant. The Company shall, upon the written request of the Holder of the
Warrant at any time, furnish or cause to be furnished to such Holder a like certificate setting forth: (i) all such adjustments
and readjustments that have been effected under the Warrant; (ii) the Exercise Price at the time in effect and (iii) the number
of shares of Exercise Shares, the type of Exercise Shares and the amount, if any, of other property that at the time would be
received upon the exercise of the Warrant.

 

5.2
          Automatic Conversion. Upon the automatic conversion of all
outstanding shares of the series of equity securities comprising the Exercise Shares, this Warrant shall become exercisable for
that number of shares of Common Stock of the Company into which the Exercise Shares would then be convertible, so long as such
shares, if this Warrant had been exercised prior to such offering, would have been converted into shares of the Company’s
Common Stock pursuant to the Company’s Certificate of Incorporation. In such case, all references to “Exercise Shares”
shall mean shares of the Company’s Common Stock issuable upon exercise of this Warrant, as appropriate.

 

6.
          FRACTIONAL SHARES. No fractional shares shall be issued upon the exercise
of this Warrant as a consequence of any adjustment pursuant hereto. All Exercise Shares (including fractions) to be issued upon
exercise of this Warrant shall be aggregated for purposes of determining whether the exercise would result in the issuance of
any fractional share. If, after aggregation, the exercise would result in the issuance of a fractional share, the Company shall,
in lieu of issuance of any fractional share, pay the Holder otherwise entitled to such fraction a sum in cash equal to the product
resulting from multiplying the then current fair market value of one Exercise Share by such fraction. 

	 

     

     

    

7.
          NOTICE OF ACQUISITION. In the event of, at any time during the Exercise
Period, an IPO or an Acquisition, the Company shall provide to the Holder 30 days’ advance written notice of such IPO or
Acquisition.

 

8.
          MARKET STAND-OFF AGREEMENT. Holder hereby agrees that Holder shall
not sell, dispose of, transfer, make any short sale of, grant any option for the purchase of, or enter into any hedging or similar
transaction with the same economic effect as a sale, any shares of Common Stock (or other securities) of the Company held by Holder
(other than those included in the registration) (i) during the 180-day period following the effective date of the IPO (or such
longer period as the underwriters or the Company shall request in order to facilitate compliance with FINRA Rule 2711 or NYSE
Member Rule 472 or any successor or similar rule or regulation), and (ii) the 90-day period following the effective date of a
registration statement of the Company filed under the Securities Act (or such longer period as the underwriters or the Company
shall request in order to facilitate compliance with FINRA Rule 2711 or NYSE Member Rule 472 or any successor or similar rule
or regulation); provided, that, with respect to (i) and (ii) above, all officers and directors of the Company and holders of at
least one percent of the Company’s voting securities are bound by and have entered into similar agreements. Holder agrees
that any transferee of the Warrant (or other securities) of the Company held by Holder shall be bound by this Section 8. The underwriters
of the Company’s stock are intended third party beneficiaries of this Section 8 and shall have the right, power and authority
to enforce the provisions hereof as though they were a party hereto.

 

9.
          NO STOCKHOLDER RIGHTS. This Warrant in and of itself shall not entitle
the Holder to any voting rights or other rights as a stockholder of the Company.

 

10.
        TRANSFER OF WARRANT. This Warrant and all rights hereunder are not transferable
by the Holder other than, for a Holder that is a partnership, limited liability company, corporation, or venture capital fund,
to (i) a partner of such partnership, a member of such limited liability company, or stockholder of such corporation, (ii) an
affiliate of such partnership, limited liability company or corporation (including, any affiliated investment fund of such Holder),
(ii) a retired partner of such partnership or a retired member of such limited liability company, or (iii) the estate of any such
partner, member, or stockholder (such transfer, an “Affiliate Transfer” and such transferees an “Affiliate
Transferee”).

 

Affiliate
Transfers may be made upon delivery of this Warrant and the form of assignment attached hereto to any Affiliate Transferee designated
by Holder. The Company represents that it has taken all action necessary to exempt an Affiliate Transfer from any such applicable
transfer restrictions. The Affiliate Transferee shall sign an investment letter in form and substance satisfactory to the Company.

 

11.
        LOST, STOLEN, MUTILATED OR DESTROYED WARRANT. If this Warrant is lost, stolen,
mutilated or destroyed, the Company may, on such terms as to indemnity or otherwise as it may reasonably impose (which shall,
in the case of a mutilated Warrant, include the surrender thereof), issue a new Warrant of like denomination and tenor as the
Warrant so lost, stolen, mutilated or destroyed. Any such new Warrant shall constitute an original contractual obligation of the
Company, whether or not the allegedly lost, stolen, mutilated or destroyed Warrant shall be at any time enforceable by anyone. 

	 

     

     

    

12.
        AMENDMENT. Any term of this Warrant may be amended or waived with the written
consent of the Company and Holder.

 

13.
        NOTICES, ETC. All notices required or permitted hereunder shall be in writing
and shall be deemed effectively given: (a) upon personal delivery to the party to be notified, (b) when sent by confirmed facsimile
or email if sent during normal business hours of the recipient, if not, then on the next business day, (c) five days after having
been sent by registered or certified mail, return receipt requested, postage prepaid, or (d) one day after deposit with a nationally
recognized overnight courier, specifying next day delivery, with written verification of receipt. All communications shall be
sent to the Company at the address listed in the Consulting Agreement or at such other address as the Company or Holder may designate
by 10 days’ advance written notice to the other parties hereto.

 

14.
        ACCEPTANCE. Receipt of this Warrant by the Holder shall constitute acceptance
of and agreement to all of the terms and conditions contained herein.

 

15.
        GOVERNING LAW. This Warrant and all rights, obligations and liabilities hereunder
shall be governed by and construed under the laws of the State of Delaware as applied to agreements among Delaware residents,
made and to be performed entirely within the State of Delaware without giving effect to conflicts of laws principles.

 

16.
        REGISTRATION RIGHTS. If the Company grants, or has granted, any other person or
entity registration rights with respect to the Common Stock of the Company, then the Company shall enter into a substantially
similar registration rights agreement with Holder with respect to the Exercise Shares, granting such Exercise Shares pari passu
registration rights.

 

	 

     

     

    

IN
WITNESS WHEREOF, the Company has caused this Warrant to be executed by its duly authorized officer as of the date first set forth
above.

 

	HOLDER:	 	COMPANY:	 
	 	 	 	 	 	 
	Agility Financial Partners, LLC	 	Electromedical Technologies, Inc.	 
	 	 	 	 	 	 
	By:	Cindy Solovei                  	 	By:	Matthew Wolfson             	 
	 	Cindy Solovei, Partner	 	 	Matthew Wolfson, CEO	 

 

[SIGNATURE
PAGE] 

	 

     

     

    

NOTICE
OF EXERCISE

 

TO:
ELECTROMEDICAL TECHNOLOGIES, INC.

 

(1)
The undersigned hereby elects to purchase                     shares
of                               (the
“Exercise Shares”) of ELECTROMEDICAL TECHNOLOGIES, INC. (the “Company”) pursuant to the terms of
the attached Warrant, and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes,
if any. If this is a Net Exercise pursuant to Section 2(b), check here: ______

 

(2)
Please issue a certificate or certificates representing said Exercise Shares in the name of the undersigned or in such other name
as is specified below:

 

 

(Name)

 

 

 

 

(Address)

 

(3)
The undersigned represents that (i) the aforesaid Exercise Shares are being acquired for the account of the undersigned for investment
and not with a view to, or for resale in connection with, the distribution thereof and that the undersigned has no present intention
of distributing or reselling such shares; (ii) the undersigned is aware of the Company’s business affairs and financial
condition and has acquired sufficient information about the Company to reach an informed and knowledgeable decision regarding
its investment in the Company; (iii) the undersigned is experienced in making investments of this type and has such knowledge
and background in financial and business matters that the undersigned is capable of evaluating the merits and risks of this investment
and protecting the undersigned’s own interests; (iv) the undersigned understands that Exercise Shares issuable upon exercise
of this Warrant have not been registered under the Securities Act of 1933, as amended (the “Securities Act”),
by reason of a specific exemption from the registration provisions of the Securities Act, which exemption depends upon, among
other things, the bona fide nature of the investment intent as expressed herein, and, because such securities have not been registered
under the Securities Act, they must be held indefinitely unless subsequently registered under the Securities Act or an exemption
from such registration is available; (v) the undersigned is aware that the aforesaid Exercise Shares may not be sold pursuant
to Rule 144 adopted under the Securities Act unless certain conditions are met and until the undersigned has held the shares for
the number of years prescribed by Rule 144, that among the conditions for use of the Rule is the availability of current information
to the public about the Company and the Company has not made such information available and has no present plans to do so; and
(vi) the undersigned agrees not to make any disposition of all or any part of the aforesaid shares of Exercise Shares unless and
until there is then in effect a registration statement under the Securities Act covering such proposed disposition and such disposition
is made in accordance with said registration statement, or, if reasonably requested by the Company, the undersigned has provided
the Company with an opinion of counsel, if requested, satisfactory to the Company, stating that such registration is not required. 

	 

     

     

    

	 	 	 
	(Date)	 	(Signature)
	 	 	 
	 	 	 
	 	 	(Print name)

	 

     

     

    

ASSIGNMENT

FORM

 

	 	(To
    assign the foregoing Warrant, execute this form and supply required information. Do not use this form to purchase shares.)	 

 

FOR
VALUE RECEIVED, the foregoing Warrant and all rights evidenced thereby are hereby assigned to

 

	Name:	 
	 	(Please
	 	 
	Address	 
	 	Print)
	 	 
	 	(Please
	 	 
	 	Print)

 

Dated:                          ,
20__ 

 

Holder’s

 

Signature:                                                                     

 

Holder’s 

Address:                                                          

 

NOTE:
The signature to this Assignment Form must correspond with the name as it appears on the face of the Warrant, without alteration
or enlargement or any change whatever. Officers of corporations and those acting in a fiduciary or other representative capacity
should file proper evidence of authority to assign the foregoing Warrant.Exhibit
10.5

 

STOCK ISSUANCE AGREEMENT

 

This
Stock Issuance Agreement (“Agreement”) is entered into as of the 29th day of November 2018 by and between
Electromedical Technologies, Inc., a Delaware corporation (the “Company”), and E-Business International, Inc., an
Oregon company, (“EBI”).

 

WHEREAS,
on or about 2005, EBI began rendering services to the Company; and

 

WHEREAS,
EBI has performed services to the Company and is currently owed $175,770.88 for said services as evidenced by EBI’s
Statement to the Company dated November 5, 2018; and

 

WHEREAS
the Company and EBI have agreed that in lieu of a cash payment to EBI that the Company will issue shares of its restricted
common stock at an initial price of $0.71 per share in full satisfaction of the current debt owed by the Company to EBI.

 

NOW
THEREFORE, in consideration of the mutual covenants and agreements set forth herein, and for other good and valuable consideration,
the receipt and adequacy of which is hereby acknowledged, the parties hereby agree as follows:

 

	 	1.	ISSUANCE OF
    SHARES. In consideration of the cancellation by EBI of the $175,770.88 owed to it by the Company and for a full release
    of that amount owed by the Company to EBI, and for EBI’s development of the Company’s new Wellness Pro Pod device
    in accordance with Addendum A attached hereto, the Company hereby agrees to issue 247,565 shares (the “Shares”)
    of its restricted common stock in full and complete release of any and all claims which EBI may have against the Company for
    the $175,780.88.

 

	 	2.	CERTAIN ADJUSTMENTS.
    If prior to the issuance of the Shares, the Company, (i) pays a stock dividend or otherwise makes a distribution or
    distributions payable in shares of Common Stock on shares of Common Stock or any Common Stock Equivalents (which, for the
    avoidance of doubt, shall not include any shares of Common Stock issued by the Company pursuant to this Agreement, (ii) subdivides
    outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way of a reverse stock split)
    outstanding shares of Common Stock into a smaller number of shares or (iv) issues, in the event of a reclassification of shares
    of the Common Stock, any shares of capital stock of the Company, then the purchase price of $0.71 per share shall be multiplied
    by a fraction of which the numerator shall be the number of shares of Common Stock (excluding any treasury shares of the Company)
    outstanding immediately before such event, and of which the denominator shall be the number of shares of Common Stock outstanding
    immediately after such event. Any adjustment made pursuant to this section) shall become effective immediately after the record
    date for the determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately
    after the effective date in the case of a subdivision, combination or re-classification. Furthermore, if at the time EBI elects
    to have the restrictive legend removed from the Shares, the average trading price of the Company’s common stock over
    the last twenty (20) days is less than $0.71 per share, the number of shares issued shall be adjusted such that the Shares
    shall be worth $175,780.88.

 

    Page 1 of 5 

     

    

	 	3.	DISCLOSURE. In accepting the Shares in full payment in the amount owed to it, EBI acknowledges the following:

 

	 	3.1	The Company has
    made available to EBI, or to EBI’s attorney, accountant or representative, all documents that EBI has requested and
    EBI has requested all documents and other information that EBI has deemed necessary or appropriate for purposes of evaluating
    the Shares in full payment for the amount owed to it by the Company.

 

	 	3.2	The Company has
    provided satisfactory answers to all questions concerning the Shares.

 

	 	3.3	EBI has carefully
    considered and has, to the extent EBI believes such discussion necessary, discussed with EBI’s professional legal, tax
    and financial advisers the suitability of accepting the Shares in full satisfaction of the amount owed for EBI’s services.

 

	 	3.4	EBI has read all
    of the Company’s filings on the SEC’s Edgar website and EBI acknowledges that it fully understands all the disclosures
    including the Company’s business plan in those filings.

 

	 	4.	OTHER SECURITIES ISSUES. EBI represents
    and warrants to the Company that:

 

	 	4.1	Risk of Loss.
    EBI recognizes that the Company is not a reporting Company with the SEC, and its stock is not yet listed for trading on any
    medium.

 

	 	4.2	Investment Intent. EBI certifies that
    it is acquiring the Shares for investment and for its own account and not on behalf of any other person.

 

	 	4.3	No Registration.
    EBI acknowledges and understands that the Shares (a) have not been registered under either federal or state securities laws,
    and (b) are being issued EBI pursuant to exemptions from registration under the Securities Act of 1933 and comparable state
    securities exemptions.

 

	 	4.4	Limited Reliance.
    EBI has relied solely on the information contained in this Agreement and its own investigation of the Company in making a
    decision to acquire the Shares. EBI has not relied on any representations or warranties made by anyone apart from those set
    forth in this Agreement.

 

	 	4.5	Legend. EBI
    consents to the placement of a legend on the certificates, if any, that represent the Securities in substantially the following
    form:

 

“THE
SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933 NOR REGISTERED NOR QUALIFIED
UNDER ANY STATE SECURITIES LAWS. SUCH SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, DELIVERED AFTER SALE, TRANSFERRED, PLEDGED,
OR HYPOTHECATED UNLESS QUALIFIED AND REGISTERED UNDER APPLICABLE STATE AND FEDERAL SECURITIES LAWS OR UNLESS, IN THE OPINION OF
COUNSEL REASONABLY SATISFACTORY TO THE CORPORATION, SUCH QUALIFICATION AND REGISTRATION IS NOT REQUIRED.”

 

and
any other legend the Company determines is authorized or required pursuant to this Agreement. This restrictive legend shall remain
of the certificate for a period of one year, after which the shares may be available for legend removal and only after the legend
is removed, may be traded without restriction. 

 

    Page 2 of 5 

     

    

	 	5.	GOVERNING
    LAW/JURISDICTION. This Agreement shall be exclusively governed by and construed in accordance with the laws of the
    State of Arizona. If any action is brought between the parties with respect to this Agreement or otherwise, by way of a claim
    or counterclaim, the parties agree that in any such action, and on all issues related to this Agreement or otherwise, the
    parties irrevocably waive their right to a trial by jury. Exclusive jurisdiction and venue for any such action shall be the
    State Courts of Arizona. In the event suit or action is brought by any party under this Agreement to enforce any of its terms,
    or in any appeal therefrom, it is agreed that the prevailing party shall be entitled to reasonable attorney’s fees at
    trial and all appellate levels. The Parties further acknowledge that they will accept service of process by registered or
    certified mail or the equivalent directed to their last known address as determined by the other Party in accordance with
    this agreement or by whatever other means are permitted by such courts. The Parties further acknowledge that said court has
    exclusive jurisdiction over any such dispute or controversy, and that they hereby waive any objection to personal jurisdiction
    or venue in this court or that such court is an inconvenient forum.

 

	 	6.	GENERAL PROVISIONS.
    This Agreement is binding upon EBI, and its successors and assigns. If any portion of this Agreement is held to be invalid,
    the remaining terms of this Agreement shall remain in full force and effect to the extent possible. This Agreement constitutes
    the entire agreement of the parties, and supersedes all previous agreements, written or oral, with regard to the amount owed
    to EBI and the Shares. Any agreement to waive or modify any term of this Agreement must be in writing signed by both parties.
    This Agreement may be executed in two or more counterparts, all of which shall constitute but one and the same instrument.

 

    Page 3 of 5 

     

    

	 	7.	COMPETION
    OF THE PROJECT. As further consideration for the Shares, EBI agrees to provide additional design and development for
    the Company’s new Wellness Pro Pod Bioelectronics device and accessories in accordance with Addendum A attached hereto,
    and to complete the project in accordance with and pursuant to the attached Design and Manufacturing Scope of Project. All
    intellectual property, including and electronic and written files, software, firm ware and technical files shall be the sole
    and exclusive property of the Company and delivered to the Company upon request.

 

	 	8.	NOTICES.
    Any and all notices and other communications required or permitted to be given pursuant to this Agreement shall be in writing
    and shall be deemed to have been duly given (a) when delivered by hand; (b) when emailed; (c) two days after having been delivered
    to Federal Express, DHL, UPS, Airborne or another recognized overnight courier or delivery service, 8 when delivered by facsimile
    transmission, provided that an original copy of such transmission shall be sent by first class mail, postage prepaid; or (d)
    five days after having been deposited into the United States mail, by registered or certified mail, return receipt requested,
    postage prepaid, to the respective parties at their respective addresses or to their respective facsimile telephone numbers,
    as follow:

 

	If to the Company:	Electromedical Technologies,
    Inc.
	 	Atten: Matthew N. Wolfson, CEO
	 	16561 N 92nd Street
	 	Suite 101
	 	Scottsdale, AZ 85260
	 	ceo@electromedtech.com
	 	 
	With a copy to:	Eric P. Littman, Esquire
	 	Eric P. Littman, P.A.
	 	7695 SW 104th Street
	 	Suite 201
	 	Miami, FL 33156
	 	Email: littmanlaw@gmail.com
	 	 
	If to EBI:	E-Business International, Inc.
	 	Atten: Dr. George Want
	 	15244 N.W. Greenbrier Parkway
	 	Beaverton, OR 97006
	 	Email: George.wang@e-bi.com

 

AGREED
to the date written above.

 

	ELECTROMEDICAL TECHNOLOGIES,
    INC.
	 	 
	By:	 	 
	 	Matthew N. Wolfson, CEO	 

 

    Page 4 of 5 

     

    

	E-BUSINESS INTERNATIONAL, INC.,	 
	 	 
	By:	 	 
	 	 Dr. George
    Want, CEO	 

 

    Page 5 of 5

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00322-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00322-of-00352.parquet"}]]